NORTHWESTERN UNIVERSITY
SCOTTSDALE, Ohio
Total Received
$896.4M
Total Awards
422
State
Ohio
Last Updated
Mar 20, 2026
Yearly Funding Trend
$757.2M24
$121.7M25
$17.5M26
Top 50 Awards to NORTHWESTERN UNIVERSITY
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_U01HL125177_075 PULMONARY VASCULAR DISEASE PHENOMICS PROGRAM (PVDOMICS) DATA COORDINATING CENTER - DESCRIPTION (PROVIDED BY APPLICANT): PROJECT SUMMARY/ABSTRACT PULMONARY HYPERTENSION (PH) IS A P… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $20,020,754 |
ASST_NON_P50AA024333_075 ALCOHOL AND TISSUE INJURY, FROM MECHANISMS TO TREATMENTS - ABSTRACT ALCOHOL ABUSE IS A LEADING CAUSE OF MORBIDITY AND MORTALITY WORLDWIDE AND RECENT DATA INDICATE THAT ALCOHOLIC L… | Department of Health and Human Services National Institutes of Health | 93.273 ALCOHOL RESEARCH PROGRAMS | CLEVELAND, OH-11 | 2024 | $16,385,490 |
ASST_NON_P30AG072959_075 CLEVELAND ALZHEIMERS DISEASE RESEARCH CENTER - PROJECT SUMMARY THE CLEVELAND ALZHEIMER'S DISEASE RESEARCH CENTER (CADRC) IS A COLLABORATIVE EFFORT OF PHYSICIANS AND INVESTIGATORS… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $15,367,621 |
ASST_NON_U01NS100610_075 DEMENTIA WITH LEWY BODIES CONSORTIUM - PROJECT SUMMARY IT HAS BEEN ESTIMATED THAT OVER 1.4 MILLION PEOPLE IN THE UNITED STATES SUFFER FROM LEWY BODY DEMENTIA (LBD), INCLUDING BOT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $14,015,195 |
ASST_NON_P01HL147823_075 GUT MICROBIOTA AND CARDIOMETABOLIC DISEASES - GUT MICROBIOTA AND CARDIOMETABOLIC DISEASES. ABSTRACT: THE OVERARCHING MISSION OF OUR PROGRAM IS TO GENERATE CRITICAL SCIENTIFIC DIS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2026 | $12,127,732 |
ASST_NON_P01HL154811_075 CELL ADHESION AND SIGNALING IN BLOOD AND VASCULAR CELLS - PROJECT SUMMARY THIS APPLICATION HAS AS ITS THEME THE INTEGRINS, THEIR REGULATION AND THEIR CONTRIBUTION TO THE FUNCTIONA… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $12,074,218 |
ASST_NON_R01AG022304_075 IMMUNE MECHANISMS UNDERLYING THE NEUROPROTECTIVE EFFECTS OF PHYSICAL ACTIVITY IN HUMAN AND MOUSE MODELS OF GENETIC RISK FOR ALZHEIMERS DISEASE - NO ABSTRACT AVAILABLE | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $11,599,603 |
ASST_NON_P01HL158502_075 ATRIAL FIBRILLATION POST-GWAS: MECHANISMS TO TREATMENT - OVERALL COMPONENT PROJECT/SUMMARY ABSTRACT ATRIAL FIBRILLATION (AF), THE MOST COMMON CARDIAC ARRHYTHMIA, AFFLICTS THE U.S.… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $11,309,762 |
ASST_NON_R01HL103866_075 GUT FLORA METABOLISM OF DIETARY CARNITINE AND CARDIOVASCULAR DISEASE - THIS APPLICATION IS A COMPETITIVE RENEWAL FOR 1R01HL103866, NAMED “GUT FLORA METABOLISM OF DIETARY CARNITINE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2025 | $10,819,349 |
ASST_NON_P01CA245705_075 SEX-BASED DIFFERENCES IN GLIOMA - PROJECT SUMMARY GLIOBLASTOMA (GBM), THE MOST COMMON PRIMARY MALIGNANT BRAIN TUMOR, REMAINS UNIFORMLY LETHAL DESPITE AGGRESSIVE THERAPIES. EPIDEMI… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | CLEVELAND, OH-11 | 2024 | $10,414,912 |
ASST_NON_U01DK061732_075 CONTINUATION OF THE NONALCOHOLIC STEATOHEPATITIS CLINICAL RESEARCH NETWORK (NASH CRN) CLINICAL CENTER-CLEVELAND SITE - THIS APPLICATION IS A COMPETITIVE RENEWAL OF THE CLEVELAND S… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | CLEVELAND, OH-11 | 2024 | $9,226,976 |
ASST_NON_U01DK114156_075 ALLIANCE OF RANDOMIZED TRIALS OF MEDICINE VS METABOLIC SURGERY IN TYPE 2 DIABETES - (ARMMS-T2D) - ABSTRACT THE SHORT-TERM SAFETY AND EFFICACY OF BARIATRIC/METABOLIC SURGERY FOR TH… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | CLEVELAND, OH-11 | 2024 | $8,849,108 |
ASST_NON_P01CA272161_075 MOLECULAR DISSECTION OF CYTOKINE CROSSTALK IN THE TUMOR MICROENVIRONMENT - PROJECT SUMMARY DESPITE RECOGNITION OF THE BROAD CONSEQUENCES OF INFLAMMATION IN CANCER BIOLOGY, THE MEC… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | CLEVELAND, OH-11 | 2024 | $7,530,252 |
ASST_NON_R01AG070736_075 CYCLE-AD: RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFICACY OF INDOOR CYCLING IN SLOWING DISEASE PROGRESSION IN HEALTHY OLDER PERSONS AT GENETIC RISK FOR ALZHEIMERS DISEASE - PR… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $7,389,501 |
ASST_NON_R01AI040459_075 POST-TRANSPLANT INFLAMMATORY RESPONSE - ABSTRACT ACUTE ALLOGRAFT REJECTION IS A T CELL MEDIATED IMMUNE RESPONSE THAT CONTINUES TO UNDERMINE THE SUCCESS OF TRANSPLANTATION TO TREAT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $7,333,924 |
ASST_NON_U01NS116776_075 CENTRAL VEIN SIGN: A DIAGNOSTIC BIOMARKER IN MULTIPLE SCLEROSIS - PROJECT SUMMARY/ ABSTRACT THE DIAGNOSIS OF MULTIPLE SCLEROSIS (MS) IS CURRENTLY BASED ON DEMONSTRATION OF DISSEMI… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CLEVELAND, OH-11 | 2024 | $7,138,910 |
ASST_NON_R35CA232097_075 TOWARDS PRECISION IMMUNO-ONCOLOGY: UNRAVELING THE GENOMIC DETERMINANTS AND MECHANISMS UNDERLYING IMMUNOTHERAPY EFFICACY AND RESISTANCE - PROJECT SUMMARY/ABSTRACT TITLE: TOWARDS PR… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | CLEVELAND, OH-11 | 2024 | $7,038,856 |
ASST_NON_R35NS097303_075 PATHOGENESIS OF NEUROLOGICAL DISABILITY IN PRIMARY DISEASES OF MYELIN - ABSTRACT ACQUIRED AND INHERITED DISEASES OF MYELIN ARE THE MAJOR CAUSE OF NON-TRAUMATIC NEUROLOGICAL DISABI… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CLEVELAND, OH-11 | 2024 | $6,947,848 |
ASST_NON_UM1HL088955_075 CARDIOTHORACIC SURGICAL TRIALS NETWORK - PROJECT SUMMARY/ABSTRACT THE CLEVELAND CLINIC CARDIOTHORACIC COLLABORATIVE CLINICAL CENTER SEEKS TO RENEW ITS PARTICIPATION IN THE CARDIOT… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $6,658,747 |
ASST_NON_R01HL058758_075 MOLECULAR BASIS OF ILK-MEDIATED CELL ADHESION - THE LONG TERM GOAL OF THIS RENEWAL PROPOSAL IS TO GAIN DEEP MECHANISTIC UNDERSTANDING OF INTEGRIN-MEDIATED CELL ADHESION THAT OCCUR… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $6,512,272 |
ASST_NON_P30EY025585_075 NEI CENTER CORE GRANT FOR VISION RESEARCH - OVERALL CORE PROJECT SUMMARY THE OVERALL AIM OF THE COLE EYE INSTITUTE (CEI) CORE FACILITIES FOR VISION RESEARCH IS TO FACILITATE THE A… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | CLEVELAND, OH-11 | 2024 | $6,387,289 |
ASST_NON_U54CA274513_075 GENOMIC AND MICROENVIRONMENTAL DETERMINANTS, TEMPORAL DYNAMICS, AND TREATMENT EFFICACY OF RADIATION-BASED COMBINATION THERAPIES - PROJECT SUMMARY CROSS-TRAINING CORE CANCER IS A M… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | CLEVELAND, OH-11 | 2024 | $6,280,793 |
ASST_NON_R35CA200422_075 MOLECULAR BASIS OF KSHV ONCOGENESIS - DESCRIPTION (PROVIDED BY APPLICANT): DESPITE REMARKABLE ADVANCES IN MEDICAL RESEARCH AND TREATMENTS DURING THE 20TH CENTURY, INFECTION-… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | CLEVELAND, OH-11 | 2024 | $6,123,545 |
ASST_NON_R01AR074131_075 BEAR-MOON: A TWO ARM NONINFERIORITY BLINDED RANDOMIZED CLINICAL TRIAL COMPARING ACL REPAIR WITH BEAR DEVICE VS. STANDARD OF CARE AUTOGRAFT PATELLAR TENDON ACL RECONSTRUCTION - PRO… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $5,984,644 |
ASST_NON_R01AG073278_075 RANDOMIZED TRIAL OF ASSISTED AMBULATION TO IMPROVE HEALTH OUTCOMES FOR OLDER MEDICAL INPATIENTS - PROJECT SUMMARY/ABSTRACT FOR OLDER ADULTS, PROLONGED HOSPITALIZATION CAN LEAD TO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $5,979,214 |
ASST_NON_R01HG010092_075 ENGAGING PATIENTS IN PRENATAL GENETIC TESTING DECISIONS AS A PATHWAY TO IMPROVE OBSTETRIC OUTCOMES - THE EARLY AND ACCURATE DIAGNOSIS OF CONGENITAL ABNORMALITIES USING PRENATAL GE… | Department of Health and Human Services National Institutes of Health | 93.172 HUMAN GENOME RESEARCH | CLEVELAND, OH-11 | 2024 | $5,886,167 |
ASST_NON_R01HL071625_075 NOVEL ROLE OF INTEGRINS IN PARACRINE REGULATION OF VASCULATURE - ABSTRACT. THIS PROPOSAL AIMS TO UNDERSTAND THE NATURE OF THE CROSSTALK BETWEEN VASCULAR AND RESIDENT INNATE IMMUNE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2025 | $5,824,638 |
ASST_NON_DP1AI169444_075 DEFINING THE VIRAL PTMOME: TOWARDS THE DEVELOPMENT OF NOVEL ANTIVIRAL APPROACHES - PROJECT SUMMARY OVER THE PAST SEVERAL DECADES, THE TRADITIONAL APPROACH TO COMBATING VIRAL INFE… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | CLEVELAND, OH-11 | 2024 | $5,635,000 |
ASST_NON_R01HL096062_075 ACTIVATION OF THE BETA-3 INTEGRINS: ROLE OF THE KINDLINS - ABSTRACT THIS PROPOSAL SEEKS TO ESTABLISH THE ROLE OF KINDLIN-3 IN PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL RESPONSES. KINDL… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $5,550,911 |
ASST_NON_R35HL135795_075 THERAPEUTIC IMPLICATIONS OF MOLECULAR DEFECTS IN BONE MARROW FAILURE - ABSTRACT BONE MARROW FAILURE SYNDROMES (BMFS) INCLUDE MYELODYSPLASTIC SYNDROME (MDS), APLASTIC ANEMIA (AA) A… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $5,259,639 |
ASST_NON_R01HL094505_075 ER-TO-GOLGI TRANSPORT OF COAGULATION FACTORS V AND VIII - ER-TO-GOLGI TRANSPORT OF COAGULATION FACTORS V AND VIII COAGULATION FACTOR V (FV) AND FACTOR VIII (FVIII) ARE BOTH SECRE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $5,130,443 |
ASST_NON_UH3NS100543_075 DEEP CEREBELLAR ELECTRICAL STIMULATION FOR POST-STROKE MOTOR RECOVERY - PROJECT SUMMARY/ABSTRACT STROKE IS A DISEASE OF EPIDEMIOLOGICAL PROPORTIONS IN THE INDUSTRIALIZED WORLD AND… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | CLEVELAND, OH-11 | 2024 | $4,938,420 |
ASST_NON_R01EY017037_075 CILIA ASSEMBLY AND TRANSPORT IN PHOTORECEPTOR CELLS - PROJECT SUMMARY MUTATIONS IN CEP290 RESULT A NUMBER OF GENETIC DISEASES TERMED CILIOPATHIES, WHICH MANIFEST WITH A VARIETY OF… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | CLEVELAND, OH-11 | 2024 | $4,926,698 |
ASST_NON_RF1NS142613_075 ASSESSING NOVEL BIOMARKERS FOR COGNITIVE FLUCTUATIONS IN DLB - AGE-RELATED DISEASES, SUCH AS ALZHEIMER DISEASE (AD) AND DEMENTIA WITH LEWY BODIES (DLB), ARE DEFINING PUBLIC HEALTH… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2025 | $4,924,374 |
ASST_NON_R01NS073717_075 CYCLICAL LOWER EXTREMITY EXERCISE FOR PARKINSONS TRIAL (CYCLE TRIAL) - PROJECT SUMMARY/ABSTRACT DESPITE ADVANCES IN PHARMACEUTICAL AND SURGICAL APPROACHES TO THE TREATMENT OF PARK… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CLEVELAND, OH-11 | 2025 | $4,819,656 |
ASST_NON_U01HL143402_075 NOVEL APPROACHES TO IMPROVE PREDICTION OF CANCER-ASSOCIATED THROMBOSIS - PROJECT SUMMARY VENOUS THROMBOEMBOLISM (VTE) IS AN IMPORTANT CAUSE OF MORBIDITY AND MORTALITY IN PATIENTS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $4,738,440 |
ASST_NON_P30AG062428_075 CLEVELAND ALZHEIMER'S DISEASE RESEARCH CENTER - OVERALL PROJECT SUMMARY THE CLEVELAND ALZHEIMER’S DISEASE RESEARCH CENTER (CADRC) IS A COLLABORATIVE EFFORT AMONGST PHYSICIANS AND… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $4,566,239 |
ASST_NON_R01AR075422_075 IMAGING POST-TRAUMATIC OSTEOARTHRITIS 10-YEARS AFTER ACL RECONSTRUCTION: A MULTICENTER COHORT STUDY WITH QUANTITATIVE MRI - PROJECT SUMMARY/ABSTRACT ANTERIOR CRUCIATE LIGAMENT (A… | Department of Health and Human Services National Institutes of Health | 93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | CLEVELAND, OH-11 | 2025 | $4,564,412 |
ASST_NON_R01AI113142_075 DESIGNING INDUCTION THERAPIES TO TARGET MEMORY T CELLS IN HIGH RISK RECIPIENTS - ABSTRACT ANTIBODY-MEDIATED LYMPHOCYTE DEPLETION IS A COMMON STRATEGY TO ELIMINATE DONOR-REACTIVE T… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $4,540,278 |
ASST_NON_R01EB024573_075 REPRODUCIBILITY IN SIMULATION-BASED PREDICTION OF NATURAL KNEE MECHANICS - PROJECT SUMMARY SIMULATIONS OF KNEE BIOMECHANICS ARE INCREASINGLY UTILIZED TO DEVELOP INDIVIDUALIZED AND… | Department of Health and Human Services National Institutes of Health | 93.286 DISCOVERY AND APPLIED RESEARCH FOR TECHNOLOGICAL INNOVATIONS TO IMPROVE HUMAN HEALTH | CLEVELAND, OH-11 | 2024 | $4,462,432 |
ASST_NON_R61NS113258_075 MULTI-OMIC BIOMARKERS FOR NEUROPATHIC PAIN SECONDARY TO CHEMOTHERAPY - PROJECT SUMMARY TAXANES ARE AMONG THE MOST EFFICACIOUS CHEMOTHERAPEUTIC AGENTS AND ARE FREQUENTLY USED IN TH… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | CLEVELAND, OH-11 | 2024 | $4,371,153 |
ASST_NON_R01AG066707_075 ENDOPHENOTYPE NETWORK-BASED APPROACHES TO PREDICTION AND POPULATION-BASED VALIDATION OF IN SILICO DRUG REPURPOSING FOR ALZHEIMERS DISEASE - ALTHOUGH RESEARCHERS HAVE CONDUCTED MO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $4,300,947 |
ASST_NON_UH3HL140097_075 1/2 POMALIDOMIDE FOR BLEEDING IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) - ABSTRACT HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) IS AN INHERITED DISORDER CHARACTE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $4,256,460 |
ASST_NON_R01DE023926_075 KSHV EPIGENETIC REGULATION - PROJECT SUMMARY/ABSTRACT WHILE KSHV CAN BE DETECTED IN BLOOD AND OCCASIONALLY IN SEMEN, IT IS FREQUENTLY SECRETED IN SALIVA WHICH IS BELIEVED TO BE T… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | CLEVELAND, OH-11 | 2024 | $4,208,780 |
ASST_NON_R01EY027083_075 FGF AND HYALURONAN-MEDIATED ALTERATIONS IN EPITHELIAL-MESENCHYMAL TRANSITION AND METABOLISM OF RPE CELLS IN SORSBY FUNDUS DYSTROPHY. - PROJECT SUMMARY SORSBY FUNDUS DYSTROPHY (SFD… | Department of Health and Human Services National Institutes of Health | 93.867 VISION RESEARCH | CLEVELAND, OH-11 | 2024 | $4,002,948 |
ASST_NON_R01AI140705_075 SFTSV NONSTRUCTURAL PROTEIN NSS-MEDIATED IMMUNOPATHOGENESIS - PROJECT SUMMARY/ABSTRACT SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS (SFTSV) LISTED IN THE WORLD HEALTH ORGANI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CLEVELAND, OH-11 | 2024 | $3,978,279 |
ASST_NON_U01AG073323_075 ALZHEIMER'S MULTIOME DATA REPURPOSING: ARTIFICIAL INTELLIGENCE, NETWORK MEDICINE, AND THERAPEUTICS DISCOVERY - PROJECT SUMMARY PREDISPOSITION TO AD INVOLVES A COMPLEX, POLYGENIC,… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CLEVELAND, OH-11 | 2024 | $3,966,759 |
ASST_NON_R37CA244613_075 EXPLOITING ECOLOGY AND EVOLUTION TO PREVENT THERAPY RESISTANCE IN EGFR-DRIVEN LUNG CANCER - ABSTRACT LUNG CANCER IS THE LEADING CAUSE OF CANCER DEATHS IN THE USA, WITH AN ESTIMATE… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | CLEVELAND, OH-11 | 2024 | $3,903,192 |
ASST_NON_R01HL153175_075 FORECASTING LUNG TRANSPLANT BENEFIT: A DYNAMIC RISK MODELING APPROACH - PROJECT SUMMARY INCREASING CLINICAL DEMAND FOR LUNG TRANSPLANTS HAS EXACERBATED THE PROBLEM OF RATIONING TH… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2025 | $3,734,998 |
ASST_NON_R01HL060917_075 NITRIC OXIDE IN PULMONARY HYPERTENSION - ABSTRACT THIS IS A COMPETITIVE RENEWAL OF OUR R37 MERIT (2009-2019), WHICH AIMS TO DEFINE MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION (P… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CLEVELAND, OH-11 | 2025 | $3,718,530 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.837 — CARDIOVASCULAR DISEASES RESEARCH$206.2M
93.866 — AGING RESEARCH$117.7M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$91.8M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$78.7M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$61.4M
93.273 — ALCOHOL RESEARCH PROGRAMS$50.9M
93.396 — CANCER BIOLOGY RESEARCH$48.6M
93.867 — VISION RESEARCH$47.1M
93.395 — CANCER TREATMENT RESEARCH$27.8M
93.846 — ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH$26.5M
Source: USAspending.gov · All Recipients · Ohio